Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Paul Yanover Insider Profile
4 Followers
Paul Yanover, Director at Eterna Therapeutics, holds 5.26K shares in Eterna Therapeutics (Ticker: ERNA).
Profitable Transactions
0 out of 2 Profitable Transactions
Average Return
-37.70%
Average return per transaction
Time Frame
Compare to
Insider Roles
Director
Roles that Paul Yanover holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:May 26, 2016 - May 26, 2017
Return:-13.20%
The most profitable trade made by Paul Yanover
Paul Yanover's Trading History
List of latest transactions for each holding click on a transaction to see Paul Yanover's performance on stock
You May Also Like
Paul Yanover insider profile FAQ
What is the percentage of profitable transactions made by Paul Yanover?
The percentage of profitable transactions made by Paul Yanover is 0%.
What is the average return per transaction made by Paul Yanover?
The average return per transaction made by Paul Yanover is -37.70%.
What stocks does Paul Yanover hold?
Paul Yanover holds: ERNA stocks.
What was Paul Yanover’s latest transaction?
Paul Yanover latest transaction was an Uninformative Buy of ―.
What was Paul Yanover's most profitable transaction?
Paul Yanover’s most profitable transaction was an Informative Buy of ERNA stock on May 26, 2016. The return on the trade was -13.20%.
What is Paul Yanover's role in Eterna Therapeutics?
Paul Yanover's role in Eterna Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.